Login
$ARDX
$3.09 +$0.02 (0.65%) After hours

Company Executives

Officer Age In this role Joined 2025 pay Source
Michael Raab Also a director
President, Chief Executive Officer and Director
61 Not stated Not stated $7,796,171
Susan Hohenleitner
Chief Financial Officer
55 Since 2025
1 year
2025 $3,437,372
Felecia Ettenberg
Chief Legal Officer
55 Since 2026
this year
Not stated Not reported
Rajani Dinavahi
Chief Medical Officer
50 Since 2026
this year
Not stated Not reported
Laura Williams
Chief Patient Officer
63 Since 2025
1 year
Not stated Not reported
Michael Kelliher
Chief Business Officer
49 Since 2025
1 year
Not stated Not reported
Eric Foster
Chief Commercial Officer
51 Since 2024
2 years
Not stated Not reported
James Brady
Chief Human Resources Officer
55 Since 2025
1 year
Not stated Not reported
Mike Kelliher
Chief Business Officer
Title from the Form 4 dated Aug 21, 2026
Not stated Not stated Not stated Not reported
John Bishop
See Remarks
Title from the Form 4 dated Aug 21, 2026
64 Not stated Not stated $2,512,522
Joseph James Reilly
See Remarks
Title from the Form 4 dated Aug 21, 2026
Not stated Not stated Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
8
serving now
Independent
0 of 1
stated in the proxy; 7 not stated
Average tenure
10.0 years
from year joined
CEO also chairs the board
No
David Mott
Director Age On board Independent Committees Other public boards 2025 pay Source
David Mott
60 2009
17 years
Not stated
Audit and Compliance Committee
Novavax, Inc. $411,886
Michael Raab
61 2008
18 years
Not independent None stated Tempest Therapeutics Paid as CEO
Robert Bazemore
58 2016
10 years
Not stated None stated Nuvation Bio, Inc. $356,886
Muna Bhanji
63 2021
5 years
Not stated
Nominating and Corporate Governance Committee
Veracyte, Inc. Not stated
Richard Rodgers
59 2014
12 years
Not stated None stated Novavax, Inc. $376,886
William Bertrand, Jr., Esq.
61 2015
11 years
Not stated None stated None stated $369,386
Onaiza Cadoret-Manier
62 2020
6 years
Not stated None stated None stated $354,386
Merdad Parsey, M.D., Ph.D.
63 2025
1 year
Not stated
Nominating and Corporate Governance Committee
Arrivent Biopharma $503,349

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

1 disclosed in the proxy filed Apr 29, 2026
each of our directors and executive officers
Amount not stated

Indemnification agreements requiring the company to indemnify each director and executive officer to the fullest extent permitted by Delaware law, including expenses, judgments, penalties, fines and settlements.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support